摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[5-[{3-(3,5-bis-(1,1-dimethylethyl)-4-hydroxyphenyl)-1-oxo-2-propenyl}-amino]-2-hydroxyphenyl]-2-thiophenecarboximidamide hydrochloride | 214123-90-7

中文名称
——
中文别名
——
英文名称
N-[5-[{3-(3,5-bis-(1,1-dimethylethyl)-4-hydroxyphenyl)-1-oxo-2-propenyl}-amino]-2-hydroxyphenyl]-2-thiophenecarboximidamide hydrochloride
英文别名
N-[5-[(3-(3,5-bis-(1,1-dimethylethyl)-4-hydroxyphenyl)-1-oxo-2-propenyl}-amino]-2-hydroxyphenyl]-2-thiophenecarboximidamide hydrochloride;N-[3-[[amino(thiophen-2-yl)methylidene]amino]-4-hydroxyphenyl]-3-(3,5-ditert-butyl-4-hydroxyphenyl)prop-2-enamide;hydrochloride
N-[5-[{3-(3,5-bis-(1,1-dimethylethyl)-4-hydroxyphenyl)-1-oxo-2-propenyl}-amino]-2-hydroxyphenyl]-2-thiophenecarboximidamide hydrochloride化学式
CAS
214123-90-7
化学式
C28H33N3O3S*ClH
mdl
——
分子量
528.115
InChiKey
TUUKVJPFOCYDEV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.27
  • 重原子数:
    36
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    136
  • 氢给体数:
    5
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    methyl thiophene-2-carbimidothioate hydroiodide 、 3-[3,5-bis-(1,1-dimethylethyl)-4-hydroxyphenyl]-N-(4-hydroxy-3-aminophenyl)-2-propenamide 在 盐酸 作用下, 以 乙醚 为溶剂, 以62%的产率得到N-[5-[{3-(3,5-bis-(1,1-dimethylethyl)-4-hydroxyphenyl)-1-oxo-2-propenyl}-amino]-2-hydroxyphenyl]-2-thiophenecarboximidamide hydrochloride
    参考文献:
    名称:
    Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    摘要:
    从以下化合物组中选择的一种化合物,其化学式为 其中A是从以下组中选择的 其他取代基在规范中定义,具有抑制NO合酶产生一氧化氮的活性和/或捕获活性氧化物种的活性。
    公开号:
    US06335445B1
点击查看最新优质反应信息

文献信息

  • 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
    申请人:Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    公开号:US06340700B1
    公开(公告)日:2002-01-22
    A compound of the formula wherein the substituents are defined as in the specification and their pharmaceutically acceptable salts having NOS and ROS activity.
    该化合物的分子式如下,其中取代基的定义如规范中所述,以及其具有NOS和ROS活性的药用可接受盐。
  • New derivatives of 2-(iminomethyl) amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    申请人:SOCIETE DE CONSEILS DE RECHERCHES ET D' APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
    公开号:US20020007062A1
    公开(公告)日:2002-01-17
    A method for treating neurodegenerative diseases in a warm-blooded animal comprising administering to a warm-blooded animal in need thereof an amount of a compound of the formula 1 wherein A selected from the group consisting of hydrogen and 2 wherein the substituents are defined as set forth in the specification.
    一种治疗恒温动物神经退行性疾病的方法,包括向需要治疗的恒温动物中给予化合物1的量,其中A选自氢和2,其中取代基的定义如规范中所述。
  • New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    申请人:SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
    公开号:US20020042511A1
    公开(公告)日:2002-04-11
    A compound of the formula XXV (H) wherein the substituents are defined as set forth in the specification which are useful intermediates for the production of derivatives of 2-(iminomethyl)-imino-phenyl having inhibitory activity on NO-synthase enzymes.
    该化合物的化学式为XXV(H),其中取代基的定义如说明书中所述,这些化合物是制备具有NO合酶酶抑制活性的2-(亚胺甲基)-亚胺基苯基衍生物的有用中间体。
  • Derivatives of 2-(iminomethyl) amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    申请人:Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    公开号:US06630461B2
    公开(公告)日:2003-10-07
    A method for treating neurodegenerative diseases in a warm-blooded animal comprising administering to a warm-blooded animal in need thereof an amount of a compound of the formula wherein A selected from the group consisting of hydrogen and wherein the substituents are defined as set forth in the specification.
    一种治疗温血动物神经退行性疾病的方法,包括向需要的温血动物内注入一定量的化合物,该化合物的公式为其中A选自氢基团,取代基的定义如规范中所述。
查看更多